Yesterday, Zenabis Provides Operations Update and Highlights for December 2019. Despite a difficult year for the share price and a still large debt for the company, Zenabis Global ZENA | TSX seems to be doing quite well on the operational side.
“December 2019 delivered our largest-ever harvest.
“We also realized strong indicative demand from our provincial partners in December, resulting in our largest-ever volume of units shipped in the month. We are excited about what 2020 will bring, ”Said Kevin Coft, Chief Executive Officer of Zenabis
In addition, the company’s Instagram account tells us that Zenabis is about to release its vaping products in the coming weeks in collaboration with PAX. Zenabis signed an agreement with PAX last September for supply cannabis extracts for PAX Era Pods designed for use with the PAX Era vaporizer device.
On the Namaste by Zenabis website we can read:
Namaste has teamed up with PAX Labs to offer a selection of our best-selling strains in pre-filled Era Pods. Compatible with the PAX Era premium extract vaporizer, our pods contain 100% plant-derived ingredients without any additives.
We start with extracting cannabinoids and terpenes from our premium cannabis strains using a supercritical C02 process. Next, the cannabis oil is distilled via molecular distillation, and botanical terpenes are reintroduced to maintain the strain’s natural terpene profile and flavor.
PAX Era Pods are durable, leak-resistant and clog-free. They feature smart click technology which allows consumers to easily switch between different strains. You can even download the PAX app to unlock more features, including the ability to precisely control temperature
It is clear that the next Zenabis earning planned for mid-February (unofficial) is likely to be interesting.
With a Cap marker of a little over 40 million, Zenabis should still do much better than the $12 million in revenues last quarter.
At the time of publication, Zenabis was trading at just $0.125 cents.
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies
The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.